- ICH GCP
- US Clinical Trials Registry
- Search trials
Example: Heart Attack
Search clinical trials for: Cisplatin
Total 4353 results
-
NCT06055153Not yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
NCT06050252Not yet recruitingIntrahepatic Cholangiocarcinoma
-
NCT06048133Not yet recruitingCholangiocarcinoma | Bile Duct Cancer | Biliary Tract Carcinoma
-
NCT06040970Not yet recruitingOvarian Cancer | Malignant Neoplasm of Uterus
-
NCT06041035Not yet recruiting
-
NCT06041724Not yet recruiting
-
NCT06039631RecruitingHypopharyngeal Cancer | Larynx Cancer
-
NCT06037980Not yet recruiting
-
NCT06037655Not yet recruiting
-
NCT06031597Not yet recruitingRadiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNon-small Cell Lung Cancer Stage III
-
NCT06029270Not yet recruiting
-
NCT06023875RecruitingHead and Neck Squamous Cell Carcinoma | Locally Advanced Operable
-
NCT06022861Not yet recruiting
-
NCT06020885Recruiting
-
NCT06019130RecruitingNasopharyngeal Carcinoma | Nasopharyngeal Cancer | Nasopharynx Cancer | Nasopharyngeal Neoplasms
-
NCT06016699RecruitingHead and Neck Cancer | Oropharynx Cancer | Larynx Cancer | HNSCC | Hypopharynx Cancer
-
NCT06017297Not yet recruitingBiliary Tract Cancer | Borderline Resectable Carcinoma
-
NCT06013943RecruitingGallbladder Cancer
-
NCT06010303Not yet recruitingEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
-
NCT06009861RecruitingOropharyngeal Squamous Cell Carcinoma | Oral Squamous Cell Carcinoma
-
NCT06008106Not yet recruiting
-
NCT06008093Not yet recruiting
-
NCT06006650RecruitingChemotherapy | Esophageal Squamous Cell Carcinoma | PD-1 Inhibitor | Neoadjuvent
-
NCT06005324Not yet recruitingHPV-Negative Squamous Cell Carcinoma
-
NCT06001658Not yet recruiting
-
NCT05998941Not yet recruiting
-
NCT05996484Not yet recruitingNeoadjuvant Therapy | Esophageal Carcinoma
-
NCT05994339Not yet recruitingLung Cancer Stage III
-
NCT05994300RecruitingCervical Neoplasm | Radiotherapy; Adverse Effect | Adaptive Radiotherapy
-
NCT05993858Not yet recruitingHead and Neck Squamous Cell Carcinoma | Neoadjuvant Therapy
-
NCT05992597RecruitingRituximab, Lenalidomide, Zebutinib ,Mantle Cell Lymphoma
-
NCT05991518Recruiting
-
NCT05984342RecruitingEsophageal Squamous Cell Carcinoma
-
NCT05980715Recruiting
-
NCT05979961Not yet recruitingNasopharyngeal Carcinoma
-
NCT05978193RecruitingEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Squamous Cell Carcinoma
-
NCT05979818Not yet recruitingNon Small Cell Lung Cancer | Propranolol
-
NCT05978609RecruitingCholangiocarcinoma Non-resectable
-
NCT05973773RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion Mutation
-
NCT05975307Not yet recruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 Inhibitor
-
NCT05967182Not yet recruiting
-
NCT05966194Not yet recruiting
-
NCT05966233Not yet recruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory
-
NCT05948462Recruiting
-
NCT05947201RecruitingThe Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
-
NCT05946577Not yet recruiting
-
NCT05945823RecruitingLocally Advanced Unresectable or Metastatic Esophageal Cancer
-
NCT05944809Not yet recruitingEsophageal Cancer | Thrombocytopenia | Concurrent Chemoradiotherapy | Intensity-modulated Radiation Therapy
-
NCT05941741Not yet recruitingNasopharyngeal Carcinoma | Chemotherapy | Radiotherapy | Immune Checkpoint Inhibitor